XML 40 R27.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

NET LOSS PER SHARE (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Earnings Per Share [Abstract] |
Schedule of Earnings per Shares, basic and diluted | The table below sets forth a reconciliation of the basic and diluted earnings per share (“EPS”) calculations for the three and six months ended June 30, 2024 and 2023:
| Three Months Ended June 30, |  | Six Months Ended June 30,
($ in thousands, except share and per share amounts) | 2024 |  | 2023 |  | 2024 |  | 2023
Numerator: |  |  |  |  |  |  |
Net loss | $ | (64,300) |  |  | $ | (19,499) |  |  | $ | (81,887) |  |  | $ | (37,989) |
Denominator: |  |  |  |  |  |  |
Weighted average shares outstanding - basic | 19,147,677 |  |  | 15,969,860 |  |  | 19,069,876 |  |  | 15,639,241 |
Effect of dilutive equity awards (1) | — |  |  | — |  |  | — |  |  | — |
Weighted average shares outstanding - diluted | 19,147,677 |  |  | 15,969,860 |  |  | 19,069,876 |  |  | 15,639,241 |
Net loss per share: |  |  |  |  |  |  |
Basic | $ | (3.36) |  |  | $ | (1.22) |  |  | $ | (4.29) |  |  | $ | (2.43) |
Diluted | $ | (3.36) |  |  | $ | (1.22) |  |  | $ | (4.29) |  |  | $ | (2.43) |
(1) Due to the Company’s net loss, all unvested equity awards, and the Private Placement Warrants are anti-dilutive. The dilutive convertible instruments of the Backstop Notes are out of the money.
Schedule of Diluted Shares Outstanding | Set forth in the table below is the number of securities not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Grants of RSUs with service only (i.e., time-vesting) conditions | 821,635 |  |  | 1,209,984 |  |  | 821,635 |  |  | 1,066,442 |
Common stock issuable under the Backstop Notes (1) | 1,920,007 |  |  | 1,920,007 |  |  | 1,920,007 |  |  | 1,920,007 |
Private Placement Warrants (2) | 272,779 |  |  | 272,779 |  |  | 272,779 |  |  | 272,779 |
(1) Common stock issuable under the Backstop Notes is presented at the maximum number of shares of common stock potentially issuable upon the exercise of the Backstop Notes, although the actual potentially issuable shares remain limited at 9.9% of the common stock outstanding. (2) The number of shares of common stock covered by warrants outstanding at the effective time of the reverse stock split was reduced to one-fifth the number of shares of common stock covered by the warrants immediately preceding the reverse stock split, and the exercise price per share was increased by five times the exercise price immediately preceding the reverse stock split, resulting in the same aggregate price being required to be paid therefor upon exercise thereof as was required immediately preceding the reverse stock split.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration